Actinolysat in treatment of actinomycotic diseases of lacrimal passages
In this paper we confirm the effectiveness and validity of using «Actinolysat» medicine in an integrated treatment of patients with actinomycotic disease of the lacrimal passages. 118 women and 10 men were examined, between the ages of 26 -85 years old. Patients had been afflicted for a period ranging from 1- 5 years. Actinomycotic etiology were confirm in 56 cases. I group - 16 patients, traditional treatment, cure -6,25%. It was established that intramuscular introduction of actinolysat medicine to the 10 patients (II group) in an integrafed conservative treatment of actinomycotic canaliculitis and dacryostenosis resulted with a complete recovery 100,0%. Extra bathings of lacrimal passeges with actinolysat obtained a complete result for all patients II group without surgical intervention. 30 patients (III group) actinomycotic canaliculitis and dacryocictitis treatment actinolisati and surgical intervention - cure 93,3%.